Come up with a name for your new list and we'll add to it:
AmpliMed raised a round of funding on January 18, 2009. Investors include
Qualifying Therapeutic Discovery Project.
AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels o…